COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

New European Guidelines on Pulmonary Embolism: What Has Changed and …

PERT Consortium 2021

S. Konstantinides

Interstitial Lung Disease in Rheumatic Diseases

University of Colorado Department of Medicine

M. Griffith

Pulmonary Hypertension: The Basic Essential Facts

Mount Sinai Advanced Heart Disease Symposium 2017

M. Trivieri

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Department of Rheumatic and Immunologic Disease

P. Grayson

VTE Prophylaxis After THA for Asian Population: Pharmacological Prop…

Arthroplasty Society in Asia

M. Mihara

VTE Prophylaxis After THA in the Asians: Messages from 2019 AP VTE C…

Arthroplasty Society in Asia

A. Tanavalee

VTE Prophylaxis After THA: Chinese Experience

Arthroplasty Society in Asia

H. Cai

Acute DVT: When to and When Not to Intervene?

Venous Edge

S. Elias, C. Pena, C. Huff, R. Winokur, K. BROWN

CardioPulmonary Exercise Test (CPET) Interpretation for Non-Experts

National Jewish Health

L. A Manka

CHEST 2024 Insights: (Mechanical) Support in RV Failure - Let's Keep…

CHEST Annual Meeting Insights

A. Vaidya

PE, RT: Please Evaluate, don't React to Thromboembolism

South Carolina Thoracic Society

P. Forfia

Pulmonary Embolism: Where Are We in 2024?

UPMC

B. Rivera-Lebron

Right Heart Failure Secondary to Non-Group 1 PH

Mayo Clinic Pulmonary and Critical Care Educational Series

H. Cajigas

ASH 2024 Review: Advances in VTE and Cancer-Associated Thrombosis

Cleveland Clinic Taussig Cancer Institute

K. Sanfilippo

Prevention and Treatment of Cancer-Associated Thrombosis: What Are t…

James Douketis

PE - The Great Masquerader: A Disease of Many Faces: Cases Where I W…

Pulmonary Embolism 2016

V. Tapson

Management of Acute Pulmonary Embolism: How Long Do You Treat?

NYU Langone

N. Amoroso

Pulmonary Hypertension Due to Lung Disease / Chronic Pulmonary Embol…

Scripps Health

K. Fan